AI assistant
Sending…
Tyra Biosciences, Inc. — Director's Dealing 2024
Mar 20, 2024
32575_dirs_2024-03-19_ad1140b3-5fa1-4246-afb9-94bfb5d98209.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2024-03-15
Reporting Person: Harris Todd (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-15 | Common Stock | A | 1880 | $6.5790 | Acquired | 1504577 | Direct |
Footnotes
F1: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
More from Tyra Biosciences, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 2